Chinese Scientist’s Nobel Should Be Wakeup Call, Insiders Say
This article was originally published in PharmAsia News
For a nation where millions of scientific students graduate each year but there have been no Nobel Prize winners in the sciences until this week, China gave surprisingly little recognition to its first Nobel Laureate in the area during her decades-long quest to develop a traditional herbal medicine into a global malaria treatment.
You may also be interested in...
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.
With gene editing making the news again after the recent Nobel Prize for CRISPR, China’s EdiGene has been raising new funds to accelerate its pipeline to the clinic, led by a potential one-time cure for thalassemia and helped by recent regulatory changes.
Given the high number of such trials in the country, China’s National Medical Products Administration has released separate guidelines for industry on the development of gene and cell therapies and gene editing clinical research.